Liquidia Technologies Inc (LQDA) - Net Assets
Based on the latest financial reports, Liquidia Technologies Inc (LQDA) has net assets worth $195.11 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($521.92 Million) and total liabilities ($326.80 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check strategic asset allocation of Liquidia Technologies Inc to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $195.11 Million |
| % of Total Assets | 37.38% |
| Annual Growth Rate | N/A |
| 5-Year Change | -31.44% |
| 10-Year Change | N/A |
| Growth Volatility | 56.68 |
Liquidia Technologies Inc - Net Assets Trend (2016–2025)
This chart illustrates how Liquidia Technologies Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Liquidia Technologies Inc market cap and net worth.
Annual Net Assets for Liquidia Technologies Inc (2016–2025)
The table below shows the annual net assets of Liquidia Technologies Inc from 2016 to 2025. Also explore LQDA net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $44.75 Million | -42.09% |
| 2024-12-31 | $77.28 Million | +63.40% |
| 2023-12-31 | $47.29 Million | -47.70% |
| 2022-12-31 | $90.42 Million | +38.55% |
| 2021-12-31 | $65.27 Million | -8.19% |
| 2020-12-31 | $71.09 Million | +103.41% |
| 2019-12-31 | $34.95 Million | +87.01% |
| 2018-12-31 | $18.69 Million | +155.47% |
| 2017-12-31 | $-33.69 Million | -84.66% |
| 2016-12-31 | $-18.25 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Liquidia Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 54205392900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $87.00K | 0.19% |
| Other Components | $670.97 Million | 1499.45% |
| Total Equity | $44.75 Million | 100.00% |
Liquidia Technologies Inc Competitors by Market Cap
The table below lists competitors of Liquidia Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
The Swatch Group AG
F:UHRA
|
$5.89 Billion |
|
Maxscend Microelectronics Co Ltd
SHE:300782
|
$5.89 Billion |
|
Glacier Bancorp Inc
NYSE:GBCI
|
$5.89 Billion |
|
Taiwan Business Bank
TW:2834
|
$5.90 Billion |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999
|
$5.87 Billion |
|
China Coal Energy Company Limited
F:CVV
|
$5.87 Billion |
|
Fortnox AB
ST:FNOX
|
$5.87 Billion |
|
Landstar System Inc
NASDAQ:LSTR
|
$5.86 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Liquidia Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 77,275,000 to 44,748,000, a change of -32,527,000 (-42.1%).
- Net loss of 68,924,000 reduced equity.
- Other factors increased equity by 36,397,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-68.92 Million | -154.03% |
| Other Changes | $36.40 Million | +81.34% |
| Total Change | $- | -42.09% |
Book Value vs Market Value Analysis
This analysis compares Liquidia Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 126.39x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $-3.59 | $65.72 | x |
| 2017-12-31 | $-3.92 | $65.72 | x |
| 2018-12-31 | $2.61 | $65.72 | x |
| 2019-12-31 | $1.89 | $65.72 | x |
| 2020-12-31 | $2.10 | $65.72 | x |
| 2021-12-31 | $1.31 | $65.72 | x |
| 2022-12-31 | $1.48 | $65.72 | x |
| 2023-12-31 | $0.73 | $65.72 | x |
| 2024-12-31 | $0.98 | $65.72 | x |
| 2025-12-31 | $0.52 | $65.72 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Liquidia Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -154.03%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -43.53%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 7.33x
- Recent ROE (-154.03%) is below the historical average (-109.17%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -120.56% | 1.56x | 0.00x | $-14.11 Million |
| 2017 | 0.00% | -401.68% | 0.49x | 0.00x | $-25.79 Million |
| 2018 | -284.34% | -1962.92% | 0.05x | 2.64x | $-55.00 Million |
| 2019 | -136.16% | -589.48% | 0.12x | 1.97x | $-51.08 Million |
| 2020 | -84.07% | -8080.11% | 0.01x | 1.40x | $-66.87 Million |
| 2021 | -52.98% | -269.03% | 0.14x | 1.44x | $-41.11 Million |
| 2022 | -45.36% | -257.39% | 0.12x | 1.43x | $-50.06 Million |
| 2023 | -165.99% | -448.89% | 0.15x | 2.50x | $-83.23 Million |
| 2024 | -168.74% | -931.65% | 0.06x | 2.98x | $-138.12 Million |
| 2025 | -154.03% | -43.53% | 0.48x | 7.33x | $-73.40 Million |
Industry Comparison
This section compares Liquidia Technologies Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $290,420,616
- Average return on equity (ROE) among peers: -51.17%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Liquidia Technologies Inc (LQDA) | $195.11 Million | 0.00% | 1.67x | $5.88 Billion |
| Aurora Cannabis Inc (ACB) | $1.08 Million | -29.24% | 0.07x | $236.15 Million |
| ADC Therapeutics SA (ADCT) | $140.89 Million | 0.00% | 0.10x | $138.64 Million |
| Akanda Corp (AKAN) | $-3.83 Million | 0.00% | 0.00x | $1.51 Million |
| Akebia Ther (AKBA) | $-30.58 Million | 0.00% | 0.00x | $241.89 Million |
| Alkermes Plc (ALKS) | $1.11 Billion | -4.33% | 0.82x | $7.72 Billion |
| Amylyx Pharmaceuticals Inc (AMLX) | $433.43 Million | 11.37% | 0.19x | $3.58 Billion |
| Amphastar P (AMPH) | $329.25 Million | 3.20% | 0.30x | $980.07 Million |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $896.36 Million | -18.93% | 3.86x | $5.80 Billion |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $20.01 Million | -419.73% | 172.53x | $3.57 Billion |
| Anika Therapeutics Inc (ANIK) | $5.00 Million | -54.00% | 0.38x | $279.44 Million |
About Liquidia Technologies Inc
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung diseas… Read more